Aktiespot

Cibus, Inc. Aktie

CBUS

Pre-market
$1.3900-0.0800 (-5.44%)
Pre-Market:$1.3831-0.01 (-0.50%)
Chart wird geladen...
Cibus, Inc. Logo

Cibus, Inc.

Eröffnung1.4500
Hoch1.4894
Tief1.3900
Volumen323.5k
P/EN/A
Marktkapitalisierung112.55M
52-Wochen-Hoch4.1910
52-Wochen-Tief1.0900
Durchschn. Volumen537.81k
DividendeN/A
Beta1.66
EPS-1.7700

Über Cibus, Inc. Aktie

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Unternehmensinformationen

Börse: NasdaqCM (NCM)
Sektor: Sundhed
Branche: Bioteknologi
Adresse:
6455 Nancy Ridge Drive
92121 San Diego, United States
Telefon: + 858 450 0008

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
3.00
115.8%
Durchschnittliches Kursziel
14.67
955.2%
Median Kursziel
16.00
1051.1%
Höchstes Kursziel
25.00
1698.6%

Andere sehen auch: